메뉴 건너뛰기




Volumn 3, Issue 2, 2012, Pages 287-292

Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinoma

Author keywords

Apoptotic index; Chemoradiotherapy; Esophageal squamous cell carcinoma

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

EID: 84855251458     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.468     Document Type: Article
Times cited : (1)

References (26)
  • 1
    • 12944307343 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysis
    • Greer SE, Goodney PP, Sutton JE and Birkmeyer JD: Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysis. Surgery 137: 172-177, 2005.
    • (2005) Surgery , vol.137 , pp. 172-177
    • Greer, S.E.1    Goodney, P.P.2    Sutton, J.E.3    Birkmeyer, J.D.4
  • 3
    • 0038359143 scopus 로고    scopus 로고
    • A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer
    • Urschel JD and Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185: 538-543, 2003.
    • (2003) Am J Surg , vol.185 , pp. 538-543
    • Urschel, J.D.1    Vasan, H.2
  • 4
    • 41949119177 scopus 로고    scopus 로고
    • Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
    • Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D and Mayer R: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26: 1086-1092, 2008.
    • (2008) J Clin Oncol , vol.26 , pp. 1086-1092
    • Tepper, J.1    Krasna, M.J.2    Niedzwiecki, D.3    Hollis, D.4    Reed, C.E.5    Goldberg, R.6    Kiel, K.7    Willett, C.8    Sugarbaker, D.9    Mayer, R.10
  • 5
    • 73949123428 scopus 로고    scopus 로고
    • Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma
    • Lv J, Cao XF, Zhu B, Ji L, Tao L and Wang DD: Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 15: 4962-4968, 2009.
    • (2009) World J Gastroenterol , vol.15 , pp. 4962-4968
    • Lv, J.1    Cao, X.F.2    Zhu, B.3    Ji, L.4    Tao, L.5    Wang, D.D.6
  • 7
    • 0030115695 scopus 로고    scopus 로고
    • Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy
    • Muro K, Ohtsu A, Boku N, Chin K, Oda Y, Fujii T, Hosokawa K, Yoshida S and Hasebe T: Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy. Jpn J Clin Oncol 26: 65-69, 1996.
    • (1996) Jpn J Clin Oncol , vol.26 , pp. 65-69
    • Muro, K.1    Ohtsu, A.2    Boku, N.3    Chin, K.4    Oda, Y.5    Fujii, T.6    Hosokawa, K.7    Yoshida, S.8    Hasebe, T.9
  • 9
    • 0034003286 scopus 로고    scopus 로고
    • Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer
    • Kitamura K, Saeki H, Kawaguchi H, Araki K, Ohno S, Kuwano H, Maehara Y and Sugimachi K: Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterology 47: 419-423, 2000.
    • (2000) Hepatogastroenterology , vol.47 , pp. 419-423
    • Kitamura, K.1    Saeki, H.2    Kawaguchi, H.3    Araki, K.4    Ohno, S.5    Kuwano, H.6    Maehara, Y.7    Sugimachi, K.8
  • 11
    • 79960228359 scopus 로고    scopus 로고
    • Targeting heat shock proteins in cancer
    • 13 November, (E-pub ahead of print)
    • Jego G, Hazoumé A, Seigneuric R, and Garrido C: Targeting heat shock proteins in cancer. Cancer Lett: 13 November, 2010 (E-pub ahead of print).
    • (2010) Cancer Lett
    • Jego, G.1    Hazoumé, A.2    Seigneuric, R.3    Garrido, C.4
  • 12
    • 33646160992 scopus 로고    scopus 로고
    • The biology of Ku and its potential oncogenic role in cancer
    • Gullo C, Au M, Feng G and Teoh G: The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta 1765: 223-234, 2006.
    • (2006) Biochim Biophys Acta , vol.1765 , pp. 223-234
    • Gullo, C.1    Au, M.2    Feng, G.3    Teoh, G.4
  • 13
    • 19344370467 scopus 로고    scopus 로고
    • Mechanism of DNA double-strand break repair by non-homologous end joining
    • Hefferin ML and Tomkinson AE: Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst) 4: 639-648, 2005.
    • (2005) DNA Repair (Amst) , vol.4 , pp. 639-648
    • Hefferin, M.L.1    Tomkinson, A.E.2
  • 14
    • 2942567553 scopus 로고    scopus 로고
    • Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer
    • Sohda M, Ishikawa H, Masuda N, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Sakurai H and Kuwano H: Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 110: 838-844, 2004.
    • (2004) Int J Cancer , vol.110 , pp. 838-844
    • Sohda, M.1    Ishikawa, H.2    Masuda, N.3    Kato, H.4    Miyazaki, T.5    Nakajima, M.6    Fukuchi, M.7    Manda, R.8    Fukai, Y.9    Sakurai, H.10    Kuwano, H.11
  • 17
    • 21244503815 scopus 로고    scopus 로고
    • Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, ninth edition: Preface, general principles, part I
    • Japanese Society for Esophageal Diseases
    • Japanese Society for Esophageal Diseases. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, ninth edition: Preface, general principles, part I. Esophagus 1; 61-88, 2004.
    • (2004) Esophagus , vol.1 , pp. 61-88
  • 18
  • 19
    • 0034306865 scopus 로고    scopus 로고
    • High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma
    • Oka K, Suzuki Y and Nakano T: High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma. Cancer 89: 1526-1531, 2000.
    • (2000) Cancer , vol.89 , pp. 1526-1531
    • Oka, K.1    Suzuki, Y.2    Nakano, T.3
  • 21
    • 33748048523 scopus 로고    scopus 로고
    • Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases
    • Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA and Milas L: Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. Radiother Oncol 80: 185-191, 2006.
    • (2006) Radiother Oncol , vol.80 , pp. 185-191
    • Raju, U.1    Ariga, H.2    Koto, M.3    Lu, X.4    Pickett, J.5    Valdecanas, D.6    Mason, K.A.7    Milas, L.8
  • 22
    • 9344248025 scopus 로고    scopus 로고
    • A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: Differences of early radiation-induced morphological changes, especially apoptosis
    • Mitsuhashi N, Takahashi T, Sakurai H, Nozaki M, Akimoto T, Hasegawa M, Saito Y, Matsumoto H, Higuchi K, Maebayashi K and Niibe H: A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis. Int J Radiat Biol 69: 329-336, 1996.
    • (1996) Int J Radiat Biol , vol.69 , pp. 329-336
    • Mitsuhashi, N.1    Takahashi, T.2    Sakurai, H.3    Nozaki, M.4    Akimoto, T.5    Hasegawa, M.6    Saito, Y.7    Matsumoto, H.8    Higuchi, K.9    Maebayashi, K.10    Niibe, H.11
  • 24
    • 0033141367 scopus 로고    scopus 로고
    • Takegana K, Asano T, Ochiai T, Isono K, Sakiyama S and Tagawa M: Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells
    • Matsubara H, Kimura M, Sugaya M, Koide Y and Gunji Y, Takegana K, Asano T, Ochiai T, Isono K, Sakiyama S and Tagawa M: Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. Int J Oncol 14: 1081-1085, 1999.
    • (1999) Int J Oncol , vol.14 , pp. 1081-1085
    • Matsubara, H.1    Kimura, M.2    Sugaya, M.3    Koide, Y.4    Gunji, Y.5
  • 25
    • 0034987331 scopus 로고    scopus 로고
    • Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy
    • Ito T, Kaneko K, Makino R, Ito H, Konishi K, Kurahashi T, Kitahara T and Mitamura K: Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy. J Gastroenterol 36: 303-311, 2001.
    • (2001) J Gastroenterol , vol.36 , pp. 303-311
    • Ito, T.1    Kaneko, K.2    Makino, R.3    Ito, H.4    Konishi, K.5    Kurahashi, T.6    Kitahara, T.7    Mitamura, K.8
  • 26
    • 0028170993 scopus 로고
    • Willers R and Gabbert HE: P53 protein expression and prognosis in squamous cell carcinoma of the esophagus
    • Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R and Gabbert HE: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74: 2218-2223, 1994.
    • (1994) Cancer , vol.74 , pp. 2218-2223
    • Sarbia, M.1    Porschen, R.2    Borchard, F.3    Horstmann, O.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.